NeuroVive will participate at the Mitochondrial Medicine 2018 conference, on 9-11 May in Cambridge, UK.
NeuroVive presents NVP025 mitochondrial myopathy project progress at Mitochondrial Medicine conference
Lund, Sweden, 20 April 2018, NeuroVive Pharmaceutical AB ...
Breakthrough brings hope of treatments for muscle diseases
Annual General Meeting 2018
Mitochondrial Medicine 2018